Blessing Dube

422 total citations
44 papers, 283 citations indexed

About

Blessing Dube is a scholar working on Immunology, Rheumatology and Hematology. According to data from OpenAlex, Blessing Dube has authored 44 papers receiving a total of 283 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Immunology, 13 papers in Rheumatology and 8 papers in Hematology. Recurrent topics in Blessing Dube's work include Psoriasis: Treatment and Pathogenesis (16 papers), Spondyloarthritis Studies and Treatments (12 papers) and Rheumatoid Arthritis Research and Therapies (5 papers). Blessing Dube is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (16 papers), Spondyloarthritis Studies and Treatments (12 papers) and Rheumatoid Arthritis Research and Therapies (5 papers). Blessing Dube collaborates with scholars based in United States, India and Switzerland. Blessing Dube's co-authors include Robert R. McLean, James January, Alexis Ogdie, Philip J. Mease, V.N. Sehgal, Mei Liu, Sabrina Rebello, Peter Hur, Abby S. Van Voorhees and Clinton Enos and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of the Rheumatic Diseases and Journal of the American Academy of Dermatology.

In The Last Decade

Blessing Dube

38 papers receiving 268 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Blessing Dube United States 9 131 104 56 40 27 44 283
Ana María Santos Colombia 11 109 0.8× 245 2.4× 98 1.8× 15 0.4× 29 1.1× 54 389
Heidi Lausten Munk Denmark 9 85 0.6× 113 1.1× 50 0.9× 44 1.1× 36 1.3× 21 307
Catherine Stroud United Kingdom 11 27 0.2× 46 0.4× 97 1.7× 41 1.0× 17 0.6× 25 326
Kamal Aggarwal India 13 102 0.8× 38 0.4× 32 0.6× 170 4.3× 71 2.6× 56 470
Dieu‐Donné Ouedraogo Burkina Faso 10 41 0.3× 92 0.9× 46 0.8× 15 0.4× 34 1.3× 62 327
Dieter Wiek Netherlands 8 35 0.3× 145 1.4× 103 1.8× 30 0.8× 21 0.8× 15 329
Penélope Esther Palominos Brazil 12 137 1.0× 208 2.0× 108 1.9× 11 0.3× 32 1.2× 34 321
L De Clercq Belgium 6 92 0.7× 220 2.1× 94 1.7× 18 0.5× 41 1.5× 8 354
Mehmet Bülbül Türkiye 11 40 0.3× 44 0.4× 18 0.3× 8 0.2× 51 1.9× 54 378
Amy Cranston Canada 11 30 0.2× 28 0.3× 19 0.3× 9 0.2× 22 0.8× 17 357

Countries citing papers authored by Blessing Dube

Since Specialization
Citations

This map shows the geographic impact of Blessing Dube's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Blessing Dube with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Blessing Dube more than expected).

Fields of papers citing papers by Blessing Dube

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Blessing Dube. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Blessing Dube. The network helps show where Blessing Dube may publish in the future.

Co-authorship network of co-authors of Blessing Dube

This figure shows the co-authorship network connecting the top 25 collaborators of Blessing Dube. A scholar is included among the top collaborators of Blessing Dube based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Blessing Dube. Blessing Dube is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mease, Philip J., Taylor Blachley, William N. Malatestinic, et al.. (2023). Effectiveness of bDMARDs in ankylosing spondylitis patients by biologic use: experience from the CorEvitas PsA/SpA Registry. Current Medical Research and Opinion. 40(2). 315–323. 1 indexed citations
2.
Mease, Philip J., Taylor Blachley, Blessing Dube, et al.. (2022). Effectiveness of 6-month Use of Secukinumab in Patients With Psoriatic Arthritis in the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry. The Journal of Rheumatology. 49(7). 700–706. 4 indexed citations
3.
Enos, Clinton, Robert R. McLean, Tin-Chi Lin, et al.. (2022). Cardiometabolic multimorbidity is common among patients with psoriasis and is associated with poorer outcomes compared to those without comorbidity. Journal of Dermatological Treatment. 33(7). 2975–2982. 5 indexed citations
4.
Wu, Jashin J., et al.. (2021). Characterization of non‐responders to interleukin‐17 inhibitors in moderate to severe psoriasis patients enrolled in the Corrona® Psoriasis Registry. Journal of the European Academy of Dermatology and Venereology. 35(8). e531–e533. 3 indexed citations
5.
Enos, Clinton, et al.. (2021). Psoriasis Severity, Comorbidities, and Treatment Response Differ among Geographic Regions in the United States. SHILAP Revista de lepidopterología. 1(2). 100025–100025. 8 indexed citations
6.
Mease, Philip J., Robert R. McLean, Blessing Dube, et al.. (2021). Comparison of Men and Women With Axial Spondyloarthritis in the US-based Corrona Psoriatic Arthritis/Spondyloarthritis Registry. The Journal of Rheumatology. 48(10). 1528–1536. 41 indexed citations
7.
Enos, Clinton, Robert R. McLean, Tin-Chi Lin, et al.. (2021). Comorbid obesity and history of diabetes are independently associated with poorer treatment response to biologics at 6 months: A prospective analysis in Corrona Psoriasis Registry. Journal of the American Academy of Dermatology. 86(1). 68–76. 29 indexed citations
8.
Finnegan, Karen E., et al.. (2020). Primary Care Behavioral Health Integration for Anxiety Management in a Safety-Net Health Care System. Journal of Health Care for the Poor and Underserved. 31(2). 569–581. 1 indexed citations
9.
Ogdie, Alexis, Peter Hur, Mei Liu, et al.. (2020). Effect of Multidomain Disease Presentations on Patients With Psoriatic Arthritis in the Corrona Psoriatic Arthritis/Spondyloarthritis Registry. The Journal of Rheumatology. 48(5). 698–706. 21 indexed citations
10.
11.
Zallman, Leah, Fernando A. Wilson, Jim P. Stimpson, et al.. (2015). Unauthorized Immigrants Prolong the Life of Medicare’s Trust Fund. Journal of General Internal Medicine. 31(1). 122–127. 21 indexed citations
12.
Zallman, Leah, et al.. (2013). Provider's Perspectives on Building Research and Quality Improvement Capacity in Primary Care: A Strategy to Improve Workforce Satisfaction. Clinical and Translational Science. 6(5). 404–408. 11 indexed citations
13.
Dube, Blessing & James January. (2012). Factors leading to poor water sanitation hygiene among primary school going children in Chitungwiza. SHILAP Revista de lepidopterología. 3(1). 7–7. 26 indexed citations
14.
Singh, Vijay Pratap, et al.. (1993). Acquired pure red cell aplasia: is chloroquine a culprit?. PubMed. 41(9). 607–607. 3 indexed citations
15.
Dube, Blessing, et al.. (1986). Fibrinolytic abnormalities in hepatic disorders.. PubMed. 34(5). 339–41. 1 indexed citations
16.
Sehgal, V.N. & Blessing Dube. (1969). Secretory State in Vitiligo. Dermatology. 138(2). 89–92. 3 indexed citations
17.
Vn, Sehgal, SM Tuli, & Blessing Dube. (1967). Leprotic nerve abscesses in northern India.. PubMed. 35(1). 60–4. 3 indexed citations
18.
Dube, Blessing, et al.. (1966). The Macrocytosis in Cirrhosis of the Liver. Acta Haematologica. 35(1). 30–45. 5 indexed citations
19.
Dube, Blessing & Shriniwas. (1965). Pseudomonas pyocyaneus infections in Varanasi.. PubMed. 45(10). 532–6. 3 indexed citations
20.
Dube, Blessing, et al.. (1964). RHINOSPORIDIOSIS IN MANGALORE.. PubMed. 42. 59–64. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ana María Santos Breakdown of academic impact, for papers by Heidi Lausten Munk Breakdown of academic impact, for papers by Catherine Stroud Breakdown of academic impact, for papers by Kamal Aggarwal Breakdown of academic impact, for papers by Dieu‐Donné Ouedraogo Breakdown of academic impact, for papers by Dieter Wiek Breakdown of academic impact, for papers by Penélope Esther Palominos Breakdown of academic impact, for papers by L De Clercq Breakdown of academic impact, for papers by Mehmet Bülbül Breakdown of academic impact, for papers by Amy Cranston
Rankless by CCL
2026